Navigation Links
CEL-SCI Secures Manufacturing Facility for Multikine Cancer Drug
Date:8/19/2007

apy, the immune system is severely weakened and is less able to mount an effective anti-tumor immune response. Other immunotherapies are administered later in cancer therapy, which can limit their effectiveness.

CEL-SCI Corporation is developing new immune system based treatments for cancer and infectious diseases. The Company has operations in Vienna, Virginia and Baltimore, Maryland. The Company's lead product Multikine is cleared to enter a global Phase III clinical trial in advanced primary head and neck cancer patients in the U.S. and Canada. CEL-SCI's other products, which are currently in pre-clinical stage, have shown protection against a number of diseases in animal tests and are being tested against diseases associated with bio-defense and avian flu.

When used in this report, the words "intends," "believes," "anticipated" and "expects" and similar expressions are intended to identify forward-looking statements. Such statements are subject to risks and uncertainties which could cause actual results to differ materially from those projected. Factors that could cause or contribute to such differences include, an inability to duplicate the clinical results demonstrated in clinical studies, timely development of any potential products that can be shown to be safe and effective, receiving necessary regulatory approvals, difficulties in manufacturing any of the Company's potential products, inability to raise the necessary capital and the risk factors set forth from time to time in CEL-SCI Corporation's SEC filings, including but not limited to its report on Form 10- K for the year ended September 30, 2006. The Company undertakes no obligation to publicly release the result of any revision to these forward-looking statements which may be made to reflect the events or circumstances after the date hereof or to reflect the occurrence of unanticipated events.


'/>"/>
SOURCE CEL-SCI Corporation

Copyright©2007 PR Newswire.

Page: 1 2 3 4

Related medicine technology :

1. CEL-SCIS CEL-1000 Shown to Significantly Enhance Immune Response Against Avian Flu Antigen in Animals
2. CEL-SCI Presents Long-Term Cancer Survival Data With Multikine
3. CEL-SCIs Cel-1000 Shown to Significantly Enhance Immune Response Against Hepatitis B Antigen in Animals
4. Largest National U.S. Healthcare Facility MRSA Study Reveals Infection Rates Eight Times Greater Than Previous Estimates
5. Vastox Awarded £400,000 Grant to Support R&D at Carbohydrate Chemistry Facility
6. FDA Re-Inspection Results in Positive Re-Classification of Guayama Facility
7. Breast Cancer and HER-2/neu: Diagnostic Tools for Targeted Therapy
8. Data Available From Erbitux Phase III Study in First-Line Treatment of Advanced Lung Cancer
9. Clinical Study Shows Regenecare Relieves Pain and Itching of Skin Rashes Caused by Widely Used Cancer Drugs
10. Antisoma Announces Further Data From ASA404 Ovarian Cancer Trial
11. Protox Announces Positive Clinical Data from Prostate Cancer Study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/2/2015)... 2, 2015 Pharma Major Lupin Limited ... "Biocom" in Russia subject to certain ... pharmaceutical market which recorded RUB 765 billion in sales, placing ... the world in 2014 (IMS Health). For over a decade, ... continue with this trend, projecting Russia ...
(Date:7/2/2015)... DURHAM, N.C. , July 2, 2015 /PRNewswire/ ... acquisition of assets related to the ion channel biology ... had previously been obtained as part of Pfizer,s 2011 ... of Pfizer,s rights to the "Icagen" name and trademark. ... provide comprehensive services for ion channel and transporter drug ...
(Date:7/2/2015)... Research and ... of the "2015 New Frontiers in ... Technologies, Competitive Landscape" report to their ... Clinical Chemistry and Immunodiagnostics: Global Challenges, Emerging ... strategic analysis of major business opportunities emerging ...
Breaking Medicine Technology:Lupin Acquires Biocom in Russia 2Lupin Acquires Biocom in Russia 3Icagen Re-launched through XRpro Sciences Acquisition of Pfizer Team and Technology for Ion Channel and Transporter Drug R&D 2Icagen Re-launched through XRpro Sciences Acquisition of Pfizer Team and Technology for Ion Channel and Transporter Drug R&D 3Icagen Re-launched through XRpro Sciences Acquisition of Pfizer Team and Technology for Ion Channel and Transporter Drug R&D 4New Frontiers in 2015 Global Clinical Chemistry and Immunodiagnostics Market: Challenges, Emerging Technologies, Competitive Landscape 2
... Therapeutics, Inc. (OTC Bulletin Board: ECTE ), ... a non-invasive, wireless, transdermal continuous glucose monitoring (tCGM) system ... today announced results for the year ended December 31, ... through Echo,s website at www.echotx.com . ...
... March 21, 2011 CardioFocus , a venture ... disorders, has secured $5M in debt financing from ... life science companies of all sizes worldwide. CardioFocus will ... in the United States and to expand the commercialization ...
Cached Medicine Technology:Echo Therapeutics Announces 2010 Financial Results 2Echo Therapeutics Announces 2010 Financial Results 3Echo Therapeutics Announces 2010 Financial Results 4CardioFocus Secures $5M Credit Facility with Silicon Valley Bank 2
(Date:7/3/2015)... ... July 03, 2015 , ... On June ... a new SEO training system called "Page One Engine" . The program, ... has received glowing reviews from several well-known marketers. HonestyFirstReviews.com's Tiffany Hendricks has joined ...
(Date:7/3/2015)... ... July 03, 2015 , ... B. ... has been retained to lead a national president recruitment for Regional ... the healthcare industry, B. E. Smith has recently placed more than 1,000 healthcare ...
(Date:7/3/2015)... ... 2015 , ... Talcum powder attorneys representing clients in national lawsuits announce the ... Center website. Just as the previous version did, the new website will serve as ... and ovarian cancer warning information. The site is routinely updated with news articles on ...
(Date:7/3/2015)... , ... July 03, 2015 , ... Yisrayl Hawkins, Pastor ... article this week that he says will reveal biblical truth and expose popular lies ... Does Your Bible Say Don’t Have Sex”, immediately goes into the core of the ...
(Date:7/2/2015)... ... ... sweetFrog Enterprises, LLC. is pleased to announce the opening of its newest location in Dallas, ... The premium frozen yogurt chain was listed as #22 on the Inc. 500 list of ... at Bachman Lake, is located at:, 3701 W. Northwest Highway, STE 430, Dallas, TX 75220 ...
Breaking Medicine News(10 mins):Health News:Page One Engine - Review Of Dori Friend's SEO Training Course Released 2Health News:Regional Care, Inc. Retains B. E. Smith to Recruit New President 2Health News:Regional Care, Inc. Retains B. E. Smith to Recruit New President 3Health News:Talcum Powder Lawsuit News: Cancer Attorneys Launch Updated Mobile Site 2Health News:Talcum Powder Lawsuit News: Cancer Attorneys Launch Updated Mobile Site 3Health News:Yisrayl Hawkins Explains What the Bible Really Says about Sex in New Publication This Week 2Health News:sweetFrog Opens 18th Location in the Lone Star State 2
... may prevent damage to the liver caused by excessive ... Alabama at Birmingham. The findings, published online April 21, ... the way to treatments to reverse steatosis, or fatty ... and cancer. The research team, led by Victor ...
... , MONDAY, May 2 (HealthDay News) -- American workers forced ... a new study suggests. A team of U.S. researchers ... per month are at higher risk for cardiovascular disease than "light" ... month. The team at Columbia University,s Mailman School of Public ...
... hands with contaminated soap from bulk-soap-refillable dispensers can increase ... may play a role in transmission of bacteria in ... issue of the journal Applied and Environmental Microbiology ... a universally accepted practice for reducing the transmission of ...
... , MONDAY, May 2 (HealthDay News) -- Eating meals with ... study finds. Researchers pooled data from 17 earlier ... regularly for meals were 24 percent more likely to eat ... They were also less likely to suffer from eating disorders. ...
... DENVER, CO, MAY 2, 2011 Two scientists who ... been chosen to receive the 2011 March of Dimes ... OBE, DSc, FRS, professor of Human Genetics, Southampton University ... Laboratory, Salisbury, England and David C. Page, MD, director, ...
... MONDAY, May 2 (HealthDay News) -- Exercising while learning might ... researchers looked at students in grades 1 through 6 at ... in a program that incorporated physical activity and classroom lessons ... the study, the students had 40 minutes of physical education ...
Cached Medicine News:Health News:Antioxidant may prevent alcohol-induced liver disease 2Health News:Frequent Business Travel Tough on the Heart, Study Finds 2Health News:Washing with contaminated soap increases bacteria on hands 2Health News: Family Meals Keep Kids Slimmer, Healthier, Study Finds 2Health News: Family Meals Keep Kids Slimmer, Healthier, Study Finds 3Health News:Exercising While Learning Boosts Test Scores, Study Finds 2
... The Primus 96 Thermal Cyclers provide comprehensive ... They are ideal instruments for the optimization ... as for low to medium throughput PCR ... the 96 well block allows a choice ...
... TC-512 has a graphical touch screen display ... at the "touch of a screen." ... gradient, Touch Screen, Graphical Display, Memory Cards, ... Block Format, Intuitive Programmin, Free Instrument Software ...
... The Tetrad 2 thermal cycler incorporates a ... Tetrad chassis. As before, the chassis controls ... supply is internal, while a large, color LCD ... updated automatic lids -- Moto Alphas -- give ...
Dual-bay Dyad thermal cycler chassis, does not include the Alpha units (requires 2)...
Medicine Products: